Search Within

Timothy Chan

  1. "Body Imaging Service"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (4)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (10)
  2. Body Imaging Service (10)
  3. GSK Faculty (10)
  4. Radiology, Department of (10)
  5. Department of Medicine (7)
  6. Solid Tumor Oncology Division (7)

More Groups

People
  1. Andrei Holodny (4)
  2. Lee Krug (4)
  3. Maria Pietanza (4)
  4. Mark Kris (4)
  5. Michelle Ginsberg (4)
  6. William Travis (4)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2019 (2)
  4. 2013 (1)
  5. 2012 (2)
  6. 2011 (1)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Clinical Cancer Research (1)
  3. Clinical Imaging (1)
  4. Journal for ImmunoTherapy of Cancer (1)
  5. Journal of Thoracic Oncology (1)
  6. Molecular Cancer Therapeutics (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. American Association for Cancer Research (2)
  3. Elsevier Inc. (2)
  4. Biomed Central Ltd (1)
  5. Lippincott Williams & Wilkins (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting the mTOR pathway in hurthle cell carcinoma results in potent antitumor activity
    Journal Article

    Dong, Y.; Gong, Y.; Kuo, F.; Makarov, V.; Reznik, E.; Nanjangud, G. J.; Aras, O.; Zhao, H.; Qu, R.; Fagin, J. A.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy
    Journal Article

    Ged, Y.; Chaim, J. L.; DiNatale, R. G.; Knezevic, A.; Kotecha, R. R.; Carlo, M. I.; Lee, C. H.; Foster, A.; Feldman, D. R.; Teo, M. Y.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Mechanisms underlying the association between sarcopenia and poor oncologic outcomes in clear cell renal cell carcinoma
    Meeting Abstract

    Sanchez, A.; Kuo, F.; Petruzella, S.; Akin, O.; Paris, M.; Russo, P.; Chan, T. A. T.; Mourtzakis, M.; Hakimi, A. A.; Furber, H.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Alterations in DNA damage repair (DDR) genes and outcomes to systemic therapy in 225 immune-oncology (10) versus tyrosine kinase inhibitor (TKI) treated metastatic clear cell renal cell carcinoma (mccRCC) patients (pts)
    Meeting Abstract

    Ged, Y.; Chaim, J.; Knezevic, A.; Carlo, M. I.; Foster, A.; Feldman, D. R.; Teo, M. Y.; Riaz, N.; Lee, C. H.; Patil, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • MRI perfusion in determining pseudoprogression in patients with glioblastoma
    Journal Article

    Young, R. J.; Gupta, A.; Shah, A. D.; Graber, J. J.; Chan, T. A.; Zhang, Z.; Shi, W.; Beal, K.; Omuro, A. M.
    Clinical Imaging (2013)

    Fulltext@MSK | Save
  • 5-day dosing schedule of temozolomide in relapsed sensitive or refractory small cell lung cancer (SCLC) and methyl-guanine-DNA methyltransferase (MGMT) analysis in a phase II trial
    Meeting Abstract

    Drilon, A. E. D. C.; Kyuichi, K.; Huberman, K. H.; Sima, C. S.; Fiore, J. J.; Yu, H. A.; Varghese, A. M.; Sumner, D. K.; Travis, W. D.; Heguy, A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker
    Journal Article

    Pietanza, M. C.; Kadota, K.; Huberman, K.; Sima, C. S.; Fiore, J. J.; Sumner, D. K.; Travis, W. D.; Heguy, A.; Ginsberg, M. S.; Holodny, A. I.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Magnetic resonance (MR) perfusion imaging to differentiate early progression from pseudoprogression following chemoradiotherapy for glioblastoma (GBM)
    Meeting Abstract

    Graber, J. J.; Young, R. J.; Gupta, A.; Shah, A. D.; Chan, T. A.; Zhang, Z.; Shi, W.; Beal, K.; Omuro, A. M. P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of temozolomide for relapsed sensitive or refractory small cell lung cancer
    Meeting Abstract

    Pietanza, M. C.; Travis, W. D.; Chan, T. A.; Ginsberg, M. S.; Holodny, A.; Kris, M. G.; Krug, L. M.
    Pancreas (2010)

    Fulltext@MSK | Save
  • Phase II study of temozolomide for relapsed sensitive or refractory small cell lung cancer
    Meeting Abstract

    Pietanza, M. C.; Pereira, L.; Dunne, M.; Travis, W. D.; Chan, T. A.; Ginsberg, M. S.; Holodny, A.; Kris, M. G.; Krug, L. M.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save